Kevin Pacheco Barrios, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phantom Limb | 7 | 2023 | 91 | 2.840 |
Why?
|
| Motor Cortex | 10 | 2023 | 986 | 2.530 |
Why?
|
| Latin America | 6 | 2023 | 381 | 1.020 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2022 | 16 | 0.850 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2022 | 45 | 0.810 |
Why?
|
| Tension-Type Headache | 1 | 2023 | 77 | 0.800 |
Why?
|
| Diabetic Neuropathies | 2 | 2021 | 400 | 0.750 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 93 | 0.730 |
Why?
|
| Neurocysticercosis | 1 | 2021 | 62 | 0.730 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2021 | 120 | 0.720 |
Why?
|
| Spinal Cord Injuries | 3 | 2022 | 931 | 0.680 |
Why?
|
| Spinal Cord Diseases | 1 | 2021 | 298 | 0.640 |
Why?
|
| Caribbean Region | 3 | 2023 | 194 | 0.590 |
Why?
|
| Fibromyalgia | 4 | 2023 | 388 | 0.590 |
Why?
|
| Beta Rhythm | 3 | 2022 | 58 | 0.580 |
Why?
|
| Transcranial Magnetic Stimulation | 6 | 2022 | 1432 | 0.510 |
Why?
|
| Sports | 1 | 2021 | 688 | 0.510 |
Why?
|
| Migraine Disorders | 2 | 2023 | 1620 | 0.460 |
Why?
|
| Functional Laterality | 1 | 2020 | 2290 | 0.450 |
Why?
|
| Lower Extremity | 2 | 2020 | 1158 | 0.450 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 2647 | 0.440 |
Why?
|
| Peru | 7 | 2023 | 881 | 0.430 |
Why?
|
| Osteoarthritis, Knee | 4 | 2023 | 1222 | 0.410 |
Why?
|
| Patient Discharge | 2 | 2022 | 3313 | 0.410 |
Why?
|
| Evoked Potentials, Motor | 4 | 2022 | 454 | 0.390 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 1832 | 0.390 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 2046 | 0.390 |
Why?
|
| Population Surveillance | 1 | 2021 | 2616 | 0.360 |
Why?
|
| Antipsychotic Agents | 1 | 2022 | 3057 | 0.330 |
Why?
|
| Mental Disorders | 3 | 2022 | 6600 | 0.310 |
Why?
|
| Morbidity | 2 | 2022 | 1769 | 0.260 |
Why?
|
| Epilepsy | 1 | 2021 | 3310 | 0.260 |
Why?
|
| Pain Threshold | 3 | 2023 | 584 | 0.250 |
Why?
|
| Electroencephalography | 6 | 2022 | 6150 | 0.250 |
Why?
|
| Humans | 58 | 2023 | 744343 | 0.240 |
Why?
|
| Pain Measurement | 7 | 2022 | 3420 | 0.240 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2023 | 1683 | 0.240 |
Why?
|
| Models, Biological | 1 | 2020 | 9583 | 0.230 |
Why?
|
| Neuralgia | 2 | 2020 | 570 | 0.230 |
Why?
|
| Stroke | 2 | 2022 | 9981 | 0.220 |
Why?
|
| Amputees | 2 | 2020 | 75 | 0.220 |
Why?
|
| Prevalence | 4 | 2023 | 15226 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Pandemics | 2 | 2023 | 8388 | 0.200 |
Why?
|
| Brain Diseases | 2 | 2021 | 1563 | 0.200 |
Why?
|
| Alpha Rhythm | 1 | 2021 | 120 | 0.190 |
Why?
|
| Resistance Training | 1 | 2023 | 165 | 0.190 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2021 | 66 | 0.190 |
Why?
|
| Tuberculoma, Intracranial | 1 | 2020 | 8 | 0.190 |
Why?
|
| Hypertension | 1 | 2021 | 8480 | 0.190 |
Why?
|
| Theta Rhythm | 1 | 2022 | 207 | 0.180 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 128 | 0.180 |
Why?
|
| Stuttering | 1 | 2019 | 25 | 0.170 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 25043 | 0.170 |
Why?
|
| Exercise Therapy | 3 | 2023 | 906 | 0.170 |
Why?
|
| Speech Production Measurement | 1 | 2019 | 98 | 0.170 |
Why?
|
| Animal Assisted Therapy | 1 | 2019 | 13 | 0.170 |
Why?
|
| Asia | 1 | 2020 | 610 | 0.170 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 161 | 0.160 |
Why?
|
| General Practitioners | 1 | 2019 | 103 | 0.160 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 1979 | 0.160 |
Why?
|
| Population Dynamics | 1 | 2020 | 302 | 0.160 |
Why?
|
| Africa | 1 | 2020 | 673 | 0.160 |
Why?
|
| Incidence | 3 | 2021 | 20947 | 0.160 |
Why?
|
| Headache | 2 | 2023 | 1226 | 0.160 |
Why?
|
| Urban Health | 1 | 2020 | 547 | 0.150 |
Why?
|
| Neural Inhibition | 1 | 2021 | 602 | 0.150 |
Why?
|
| Arthralgia | 1 | 2022 | 456 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 895 | 0.150 |
Why?
|
| Pain | 5 | 2023 | 4986 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3079 | 0.140 |
Why?
|
| Choice Behavior | 1 | 2022 | 803 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 439 | 0.140 |
Why?
|
| Adult | 18 | 2023 | 214055 | 0.140 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 528 | 0.140 |
Why?
|
| Imagination | 1 | 2017 | 221 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 961 | 0.130 |
Why?
|
| Nerve Block | 1 | 2022 | 644 | 0.130 |
Why?
|
| HIV Infections | 1 | 2022 | 16718 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2021 | 921 | 0.130 |
Why?
|
| Patient Preference | 1 | 2022 | 890 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 9146 | 0.120 |
Why?
|
| Gait | 1 | 2020 | 793 | 0.120 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1004 | 0.120 |
Why?
|
| Home Care Services | 1 | 2020 | 606 | 0.120 |
Why?
|
| Young Adult | 9 | 2022 | 56430 | 0.120 |
Why?
|
| Self Concept | 1 | 2019 | 1025 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2020 | 810 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 7279 | 0.120 |
Why?
|
| Primary Health Care | 1 | 2020 | 4558 | 0.110 |
Why?
|
| Low Back Pain | 1 | 2022 | 956 | 0.110 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 668 | 0.110 |
Why?
|
| Female | 19 | 2023 | 380194 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2022 | 1197 | 0.110 |
Why?
|
| Respiration | 1 | 2019 | 1653 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 1392 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 3610 | 0.100 |
Why?
|
| Antitubercular Agents | 1 | 2020 | 1320 | 0.100 |
Why?
|
| Extremities | 1 | 2017 | 865 | 0.100 |
Why?
|
| Male | 16 | 2023 | 350118 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2951 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2107 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2020 | 1212 | 0.090 |
Why?
|
| Brain | 5 | 2023 | 26385 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2020 | 2925 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1534 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1622 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2023 | 2775 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.080 |
Why?
|
| Brain Mapping | 2 | 2021 | 6669 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2022 | 3265 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.080 |
Why?
|
| Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
| Hospitals | 1 | 2021 | 3952 | 0.080 |
Why?
|
| Decision Making | 1 | 2021 | 3887 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 35421 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 4931 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2023 | 53288 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14722 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 4258 | 0.070 |
Why?
|
| Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
| Life Expectancy | 2 | 2023 | 1184 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2021 | 8554 | 0.060 |
Why?
|
| Dementia | 1 | 2019 | 2518 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2023 | 9959 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2019 | 4687 | 0.060 |
Why?
|
| Middle Aged | 9 | 2023 | 213383 | 0.060 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2020 | 5027 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77449 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2021 | 12026 | 0.050 |
Why?
|
| Cortical Synchronization | 1 | 2022 | 79 | 0.050 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 1422 | 0.050 |
Why?
|
| Amphetamines | 1 | 2023 | 148 | 0.050 |
Why?
|
| Oscillometry | 1 | 2021 | 147 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2022 | 192 | 0.050 |
Why?
|
| Pain Perception | 1 | 2022 | 191 | 0.050 |
Why?
|
| Ethambutol | 1 | 2020 | 60 | 0.050 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 2147 | 0.050 |
Why?
|
| Pyrazinamide | 1 | 2020 | 54 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2020 | 137 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2022 | 63114 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2021 | 387 | 0.040 |
Why?
|
| Aged | 5 | 2023 | 163280 | 0.040 |
Why?
|
| Nystagmus, Pathologic | 1 | 2020 | 96 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 431 | 0.040 |
Why?
|
| Endemic Diseases | 1 | 2020 | 182 | 0.040 |
Why?
|
| Cognition | 3 | 2021 | 6770 | 0.040 |
Why?
|
| Sensation | 1 | 2021 | 336 | 0.040 |
Why?
|
| Quality of Life | 4 | 2022 | 12804 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2020 | 145 | 0.040 |
Why?
|
| Isoniazid | 1 | 2020 | 274 | 0.040 |
Why?
|
| Brazil | 1 | 2023 | 1270 | 0.040 |
Why?
|
| Quadriplegia | 1 | 2020 | 223 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8642 | 0.040 |
Why?
|
| Rifampin | 1 | 2020 | 315 | 0.040 |
Why?
|
| Risk Factors | 2 | 2022 | 72290 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2022 | 1240 | 0.040 |
Why?
|
| Electromyography | 1 | 2022 | 1379 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2022 | 680 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2022 | 1767 | 0.040 |
Why?
|
| Nausea | 1 | 2020 | 673 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5391 | 0.040 |
Why?
|
| Vomiting | 1 | 2020 | 636 | 0.040 |
Why?
|
| Rest | 1 | 2022 | 901 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 855 | 0.030 |
Why?
|
| Exercise | 2 | 2023 | 5615 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
| Blindness | 1 | 2020 | 617 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2021 | 1056 | 0.030 |
Why?
|
| Perfusion | 1 | 2020 | 1360 | 0.030 |
Why?
|
| Analgesics | 1 | 2022 | 1040 | 0.030 |
Why?
|
| Reading | 1 | 2019 | 558 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 985 | 0.030 |
Why?
|
| Speech | 1 | 2019 | 540 | 0.030 |
Why?
|
| Dogs | 1 | 2019 | 3912 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 2309 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2959 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1855 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2021 | 1774 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2020 | 1951 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2022 | 2161 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Heart Rate | 1 | 2023 | 4091 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 168757 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 1956 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 6993 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4623 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 12245 | 0.020 |
Why?
|
| Research Design | 1 | 2022 | 5987 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 4297 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 15540 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2023 | 25625 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 85781 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 41006 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
| Depression | 1 | 2019 | 7766 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 57776 | 0.010 |
Why?
|